Perrigo (PRGO) Misses Q4 EPS by 3c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LRCX
6. LVS
7. SAP
8. CSX
9. KNX
10. SPY

Go back to Perrigo (PRGO) Misses Q4 EPS by 3c, Revenues Beat

Perrigo Co. (PRGO) PT Lowered to $48 at RBC Capital

February 28, 2019 6:48 AM EST

RBC Capital analyst Randall Stanicky lowered the price target on Perrigo Co. (NYSE: PRGO) to $48.00 (from $50.00) while maintaining a Sector Perform rating following results.

Stanicky notes consumer margins are under pressure and they stay cautious into the May update.

... More

Perrigo (PRGO) Receives Leave To Judicially Review Irish Revenue Tax Assessment

February 25, 2019 8:39 AM EST

llPerrigo Company plc (NYSE: PRGO), a leading global provider of "Quality, Affordable, Self-Care Products", today announced that its subsidiary, Perrigo Pharma International DAC ("Elan Pharma"), has been granted leave by the Irish High Court to judicially review the November 29, 2018 issuance of a Notice of Amended Assessment by the Irish Office of the Revenue Commissioners for the calendar year ended December 31, 2013.

As... More